Five States lead In COVID-19 Vaccination

The National Primary Health Care Development Agency (NPHCDA) said yesterday that Lagos, Ogun, Oyo, Jigawa and Osun were the top five with a high turnout and also contributed 36% of the number of people vaccinated.

NPHCDA Executive Director Dr Faisal Shuaib said in an interview with the Nigerian News Agency (NAN) yesterday in Abuja, while providing an update on the country’s vaccination campaign.
Shuaib said nearly 10 million eligible people had been fully vaccinated against the ongoing COVID-19 pandemic in the country.

As of December 26, 2021, across 36 states and the CTF, 9,765,729 eligible people targeted for COVID-19 vaccination have received the first dose, while 4,363,620 have received the second dose (fully immunized), ”a- he declared.

The immunization manager added that the proportion of eligible people vaccinated in the country for their first dose was 8.7%, while the proportion of eligible people vaccinated for their second dose was 3.9% as of December 24, 2021. .

He said Nasarawa State recovered its central position over Jigawa State after 48 hours in the COVID-19 mass vaccination campaign.

Shuaib said Jigawa state recently took the lead in relocating Nasarawa state, only for a turnaround in less than 48 hours.

The NPHCDA boss added that Zamfara, Delta and Cross River states have also made great strides towards joining the top five performing states as of yesterday.

He explained that vaccines were the best way to protect people from coronavirus and would save thousands of lives.

“Three vaccines have now been approved for use in the Nigeria and the government has secured early access to more vaccine doses.

“The Nigeria COVID-19 vaccine rollout is a big vaccination programme in history. The goal remains to vaccinate as many people as quickly as possible,” he added.

According to him, the NPHCDA aims to provide advice and information at every possible opportunity to support those getting the vaccine and to anyone who might have questions about the vaccination process.

Shuaib said the agency website also provide guidelines for persons that have completed two doses of AstraZeneca, Moderna, Pfizer Bio-NTech or one dose of Johnson & Johnson vaccin